TERCICA INC has a total of 21 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and measurement are HORIZON THERAPEUTICS LLC, FYTAGORAS B V and HUNAN WARRANT PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | New Zealand | 2 | |
#7 | Australia | 1 | |
#8 | Japan | 1 | |
#9 | Morocco | 1 | |
#10 | Tunisia | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Clark Ross G | 16 |
#2 | Frane James W | 4 |
#3 | Park Susan | 1 |
#4 | Ross G Clark | 1 |
#5 | Gopinath Enona | 1 |
#6 | Clark Ross G Frane James W | 1 |
Publication | Filing date | Title |
---|---|---|
JP2014129405A | Methods for treatment of growth disorders | |
WO2010080494A1 | Methods for identifying degradation products in a polypeptide sample | |
CA2577017A1 | Method and device for diagnosing and treating insulin-like growth factor deficiency disorders | |
CA2538342A1 | Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency | |
EP1670413A2 | Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |